Winslow Evans & Crocker’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-50
Closed -$1.43K 1150
2017
Q3
$1.43K Buy
50
+1
+2% +$30 ﹤0.01% 1047
2017
Q2
$1.58K Sell
49
-1
-2% -$33 ﹤0.01% 1195
2017
Q1
$1.7K Hold
50
﹤0.01% 1155
2016
Q4
$1.73K Hold
50
﹤0.01% 1159
2016
Q3
$1.7K Hold
50
﹤0.01% 1202
2016
Q2
$1.83K Buy
50
+1
+2% +$38 ﹤0.01% 1180
2016
Q1
$1.98K Sell
49
-1
-2% -$37 ﹤0.01% 1169
2015
Q4
$1.76K Hold
50
﹤0.01% 1251
2015
Q3
$1.57K Hold
50
﹤0.01% 1204
2015
Q2
$1.67K Hold
50
﹤0.01% 1221
2015
Q1
$1.66K Hold
50
﹤0.01% 1185
2014
Q4
$1.72K Hold
50
﹤0.01% 1211
2014
Q3
$1.61K Buy
50
+1
+2% +$34 ﹤0.01% 1300
2014
Q2
$1.67K Hold
49
﹤0.01% 1210
2014
Q1
$1.72K Hold
49
﹤0.01% 1186
2013
Q4
$2K Buy
+49
New +$1.8K ﹤0.01% 1295

Other funds holding ACH

Winslow Evans & Crocker's ACH Position: Q4 2017 in Review

Winslow Evans & Crocker sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 50 shares — an estimated $1.43K sold.

Winslow Evans & Crocker first reported a position in ACH in Q4 2013 and held it in 16 quarters. The position peaked at $2K in Q4 2013. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • Winslow Evans & Crocker reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
  • Winslow Evans & Crocker sold 50 Accendra Health shares in Q4 2017, an estimated $1.43K.
  • Winslow Evans & Crocker first reported a position in Accendra Health in Q4 2013 and held it in 16 quarters.
  • Winslow Evans & Crocker's Accendra Health position peaked at $2K in Q4 2013.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Winslow Evans & Crocker's 13F filing for Q4 2017, filed 19 Jan 2018.